Aloe Blacc faces biotech funding challenges

Grammy-nominated artist Aloe Blacc discovered that funding biotech research, even for a personal cause like a better COVID solution, requires more than just financial investment. Unlike other industries, biotech demands a clear commercialization plan and navigates complex regulatory pathways. Blacc is now focusing on bootstrapping a cancer drug platform for pancreatic cancer, highlighting the significant hurdles in translating scientific innovation into viable treatments and securing necessary licenses for university intellectual property.